-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NYSE New York Stock ExchangeUSDISIN US7170811035-
PfizerBörse NYSE New York Stock ExchangeISIN US7170811035 WKN: 852009USDSymbol PFE
-
PfizerBörse Börse StuttgartISIN US717081DK61EURSymbol PFE
-
PfizerBörse Xetra FrankfurtISIN US717081ER06EURSymbol PFE
-
PFIZER INCBörse Börse HamburgISIN US717081ED10EURSymbol PFE
-
PFIZER INCBörse Börse DüsseldorfISIN XS1574158082EURSymbol PFE
-
PFIZER INCBörse Börse MünchenISIN US717081DZ31EURSymbol PFE
-
PFIZER INCBörse Gettex System der Börse MünchenISIN US717081ES88EURSymbol PFE
-
PFIZER INCBörse Tradegate System der Deutsche Börse AG (60%)ISIN US717081EQ23EURSymbol PFE
-
PFIZER INCBörse Quotrix System der Börse DüsseldorfISIN US717081DE02EURSymbol PFE
-
PFIZER INCBörse Börse FrankfurtISIN XS1574157357EURSymbol PFE
-
PfizerBörse Xetra FrankfurtEURISIN US717081EY56
-
PfizerBörse Börse MünchenEURISIN US717081FA61
-
PfizerBörse SSE Stockholm Stock ExchangeISIN US717081EZ22SEKSymbol PFE
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US717081EK52MXNSymbol PFE
-
PfizerBörse Bolsa de Comercio de Buenos AiresUSDISIN US717081DV27
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtMXNISIN US717081DH33
-
PfizerBörse BUEUSDISIN US717081EV18
-
ISIN US717081EX73EURSymbol PFE
-
PfizerBörse OMXSSEKISIN US7170811035
-
EURISIN US717081EJ89
-
PFIZER INCBörse SSEISIN US717081EP40
-
ISIN US7170811035
WKN 852009
Symbol PFE
Währung
USD
Börse
NYSE New York Stock Exchange Zeitzone: Europe/Berlin
Firmenname
Pfizer Inc
Marktkapitalisierung
197.500.079.920 (+- 10%)
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
204.882.624.512 oder 216.419.000.000 oder 171.198.615.249
Mitarbeiter
83.400 (+- 6%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
88.300 oder 78.500 Mitarbeiter
Anzahl Aktien
5.558.396.599
KGV
18.68 (+- 28%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
23.97 oder 13.4
EBITDA 19.320.000.512
PEGRatio 4.9741
Buchwert 11.744
Zahlte zuletzt am 06.05.2021 eine Dividende von 0,39 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die Dividendenrendite
entsprach 4,02 % p. a.
beim aktuellen Kurs von 36,59 USD -0,04%
Pfizer underperformed den DAX um -15 % (+31 % Dividenden) vom 21.11.2013 bis 14.09.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 36,59 USD -0,04%
Letzte Communitymeinungen
- 2 User waren zuletzt bullisch
- Im Alpha-Tester Battle 2021
-
casixxx
-
Harry386
Ein User hat Pfizer abonniert.
Aktionärsstruktur der Pfizer Inc
Portrait der Pfizer Aktie
Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.
Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.
Die Pfizer Aktie hat inklusive der Dividendenausschüttungen seit dem 21.11.2013 eine Gesamtrendite von 86% erwirtschaftet
Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
1.018 News & Informationen zur Pfizer Aktie
Canada Criticized for Covid-19 Vaccine Rollout
Authorities are scrambling to make up lost ground in rolling out the shots as the nation battles surging infections.
Moderna’s Covid-19 Vaccine Is Authorized by U.K. Regulator
The U.K.’s health regulator authorized the use of Moderna’s Covid-19 vaccine, boosting the number of different shots at the country’s disposal to three as it battles a contagious new variant of the virus.
Pharma Stock Roundup: ABBV's Positive Skyrizi Data, AZN, PFE, RHHBY's FDA Updates
AbbVie's (ABBV) Skyrizi succeeds in psoriatic arthritis and Crohn's disease studies. AstraZeneca (AZN), Pfizer (PFE) and Roche (RHHBY) give FDA updates.
Sarepta Falls 50% To 10-Month Low After DMD Gene Therapy Study Misses Primary Endpoint
Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT), which had a lot riding on its gene therapy candidate for treating Duchenne muscular dystrophy in the new …
Moderna's COVID-19 vaccine becomes third to be authorized by U.K. regulator
Biotech Moderna's undefined COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling…
Europe's drug regulator says there is an extra dose in BioNTech/Pfizer's COVID-19 vaccine vials
The European Medicines Agency said Friday that the product information for BioNTech SE undefined and Pfizer Inc.'s undefined COVID-19 vaccine should be…
Pfizer and BioNTech say COVID-19 vaccine neutralizes mutation found in new U.K., South Africa variants
Pfizer Inc. undefined and German partner BioNTech SE undefined said Friday an in vitro study found that their COVID-19 vaccine neutralizes the two new highly…
Pfizer’s Covid-19 Vaccine Delay Isn't Welcome News for PFE Stock
The UK’s chief medical officers want to delay second doses of the Pfizer/BioNTech vaccine. Is this much ado about nothing for PFE stock?
Stocks making the biggest moves in the premarket: Tesla, Micron Technology, Sarepta Therapeutics & more
The stocks making the biggest moves in premarket trading include Tesla, Micron Technology, Sarepta Therapeutics & more.
Is the Pfizer/BioNTech vaccine effective against COVID-19 mutations? Scientists have the answer
A team of scientists from Pfizer and Texas University have found that the Pfizer Inc/BioNTech vaccine is effective against the mutations present in the COVID-19 strains discovered in the UK and South Africa.
Pfizer, BioNTech Announce Results From In Vitro Study
(RTTNews) – Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced Friday results from an in vitro study conducted by Pfizer and the University of Tex…
Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants -study
NEW YORK — Pfizer Inc and BioNTech’s COVID-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus…
EU agrees new Pfizer Covid vaccine deal and secures nearly half its annual output
The EU is doubling its purchases of the Pfizer-BioNTech coronavirus vaccine at a time of growing concern over its rollout.
Pfizer (PFE) Begins Dosing in DMD Study With Gene Therapy
Pfizer (PFE) doses the first participant in the phase III CIFFREO study, evaluating its investigational gene therapy, PF-06939926, for treating boys with DMD.
Pfizer study suggests vaccine works against virus variant
The study is preliminary and has not yet been reviewed by experts, a key step for medical research
Pfizer Study Shows Vaccine Efficacious Against COVID-19 Variant
Pfizer Inc (NYSE: PFE)/BionNTech SE (NASDAQ: BNTX) COVID-19 showed signs of working against a mutation found in two highly-contagious COVID-19 …
Chinese City Locked Down; Australia Tightens Rules: Virus Update
Track the latest developments in the global Covid-19 pandemic here.
Pfizer vaccine appears effective against mutation in new coronavirus variants: Study
The not-yet peer reviewed study by Pfizer and scientists from the University of Texas Medical Branch indicated the vaccine was effective in neutralizing virus with the so-called N501Y mutation of the spike protein.
4 Health Care Stocks to Consider as Covid-19 Vaccine Distribution Continues
4 Health Care Stocks to Consider as Covid-19 Vaccine Distribution Continues, Stocks: BIIB,CVS,HUM,UHS,PFE,BNTX,MRNA,WBA, release date:Jan 06, 2021
Sound Income ETFs Bring Active Approach to Creating Retirement Income
Sound Income Strategies, a Florida-based registered investment advisory firm, is making its income-generating strategies more accessible to a broader group of investors.
Peru Slams Pfizer Over Legal Immunity For COVID Vaccine Side Effects
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
U.S. sets COVID-19 hospitalization record as states ramp up vaccination efforts By Reuters
U.S. sets COVID-19 hospitalization record as states ramp up vaccination efforts
2021 Could Be Novavax’s Year
Novavax (NASDAQ: NVAX) saw its stock gain over 3,000% last year. But it could have even more room to run as the market will get only crazier for vaccines …
EU regulator approves Moderna vaccine as fears mount over virus variants
Read more about EU regulator approves Moderna vaccine as fears mount over virus variants on Business Standard. Vaccinating the European Union’s 450 million people could be crucial to ending a pandemic that has killed almost 1.9 million people globally
Dr. Scott Gottlieb says getting vaccinated doesn’t mean people can just return to pre-Covid life
Chart Of The Day: Vaccine Maker Pfizer Has Good Shot At Heading Higher
Stocks Analysis by Investing.com (Pinchas Cohen/Investing.com) covering: Pfizer Inc. Read Investing.com (Pinchas Cohen/Investing.com)’s latest article on Investing.com
EMA Committee Recommends Conditional Approval Of Moderna’s Coronavirus Vaccine
Moderna Inc (NASDAQ: MRNA) is close to getting its fourth regulatory nod for mRNA-1273, its vaccine candidate against SARS-CoV-2.
What Happened: The …
Covid variant found in South Africa is worrying experts: Here’s what we know so far
A new strain of the coronavirus that has emerged in South Africa is causing concern around the globe.
Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know
Pfizer (PFE) closed at $37.19 in the latest trading session, marking a +1.03% move from the prior day.
Chilean lawmakers propose making coronavirus vaccine mandatory
Chilean lawmakers on Tuesday
presented a bill before Congress that would make vaccination
against the coronavirus mandatory as the country’s center-right
government pushes to inosculate the majority… | January 5, 2021
Israel to enter third national lockdown despite successful Covid vaccination campaign
Israel braces for a third national lockdown even with the nation seeing success in the rollout of the Pfizer BioNTech vaccine
EU In Talks To Buy Up To 300M More Coronavirus Vaccine Doses From Pfizer-BioNTech
With the U.K. entering a third nationwide lockdown and the COVID-19 pandemic raging through the rest of Europe, vaccines approved for emergency use …
Moderna Raises Covid-19 Vaccine Production Estimate
By Jonathan D. Rockoff
Moderna Inc. said it will be able to make at least 600 million doses of its Covid-19 vaccine this year, 100 million more than it had been projecting.
The… | January 5, 2021
Why Did Novavax Stock Decline 20% In December?
Vaccine specialist Novavax – which is seen as a key player in the Covid-19 vaccine space – saw its stock price decline by about 20% over December. Here are a few possible reasons for the decline. Covid-19 vaccines by Pfizer and Moderna received emergency approval from the U.S. FDA in December…
EU Seeks Up to 300 Million More Pfizer-BioNTech Doses
(Bloomberg) — The European Union is negotiating with Pfizer Inc. and BioNTech SE on a deal that could double their supply of Covid-19 vaccine to the region, according to people familiar with the talks.
SA offered discounted vaccines, cost still ‘prohibitive’ says president’s office
A spokeswomen for the health ministry said it cannot comment on the pricing ‘as a deal is yet to be concluded’, says Bloomberg.
Press Release: BioNTech to Present at the 39th Annual J.P. Morgan Healthcare Conference
MAINZ, GERMANY, January 5, 2021 —
https://www.globenewswire.com/Tracker?data=mW0mUhpjdzQ9lBMmo_U7TJSMUl3gi8yCLhGS9_WVtvZO0-Gc0CmQmMG8T7wnKE6TfJzklkQXwcuQ_krhrlFR5g==
BioNTech SE announced… | January 5, 2021
Pfizer Introduces New Logo Playing Up Role in Drug Creation
The company is launching its first major rebrand in decades in an effort to highlight its shift from a diversified health care giant to one more focused on creating prescription drugs and vaccines, as it brings out its Covid-19 vaccine with BioNTech.
UK decision to delay second Covid vaccine dose is proving controversial. Here’s what we know so far
The U.K.’s decision to delay giving people the second dose of a coronavirus vaccine is proving controversial, with experts and the vaccine producers weighing in.
FDA Objects to Dosage Changes; Italy Extends Curbs: Virus Update
Track the latest developments in the global Covid-19 pandemic, here.